NEUROCRINE BIOSCIENCES
Live / Applied — Statement of use — processing complete, to examiner (as of 20 Feb 2026)
What this means for you
Not registered yet, but its 16 Aug 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90884754
- Mark type
- Design + words
- Filed
- 16 Aug 2021
- Published for opposition
- 13 Dec 2022
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 042 — Scientific and technological services: pharmaceutical drug development services in the field of hormonal and genetic diseases, disorders and conditions
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 20 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Feb 2026 — USE AMENDMENT FILED
- 09 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 11 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2025 — SOU EXTENSION 5 GRANTED
- 23 Jul 2025 — SOU EXTENSION 5 FILED
- 24 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2025 — SOU EXTENSION 4 GRANTED
- 06 Feb 2025 — SOU EXTENSION 4 FILED
- 26 Feb 2025 — DIVISIONAL PROCESSING COMPLETE
- 06 Feb 2025 — DIVISIONAL REQUEST RECEIVED